Semnur Pharmaceuticals, Inc. Federal Deposit Insurance Corporation Premium Expense
Semnur Pharmaceuticals, Inc. (SMNR) reported Federal Deposit Insurance Corporation Premium Expense of $250.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FederalDepositInsuranceCorporationPremiumExpense · last filed 2024-05-22
- Semnur Pharmaceuticals, Inc. federal deposit insurance corporation premium expense for the quarter ending 2024-03-31 was $250.00K.
- Semnur Pharmaceuticals, Inc. federal deposit insurance corporation premium expense for the quarter ending 2023-12-31 was $0.00.
- Semnur Pharmaceuticals, Inc. federal deposit insurance corporation premium expense for fiscal 2023 was $250.00K.
| Period end | Federal Deposit Insurance Corporation Premium Expense 3 month | Federal Deposit Insurance Corporation Premium Expense 6 month | Federal Deposit Insurance Corporation Premium Expense 9 month | Federal Deposit Insurance Corporation Premium Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $250.00K 10-Q · filed 2024-05-22 | $250.00K derived: sum of 2 quarters · filed 2024-05-22 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $250.00K 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $250.00K 10-Q · filed 2023-11-09 |